These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 757606)
1. Heterogeneity of pathogenetic mechanisms in hyaline membrane disease. Strang LB Mead Johnson Symp Perinat Dev Med; 1978; (14):53-8. PubMed ID: 757606 [No Abstract] [Full Text] [Related]
2. The effect of prematurity and hyaline membrane disease on oxygen exchange in the lung. Woodrum DE; Oliver TK; Hodson WA Pediatrics; 1972 Sep; 50(3):380-6. PubMed ID: 5056411 [No Abstract] [Full Text] [Related]
3. The circulation, fluid transfers and surface activity in the lungs of infants with hyaline membrane disease. Normand IC Bull Physiopathol Respir (Nancy); 1973; 9(6):1473-94. PubMed ID: 4602246 [No Abstract] [Full Text] [Related]
4. Serial studies of lung volume and VA-Q in hyaline membrane disease. Tori CA; Krauss AN; Auld PA Pediatr Res; 1973 Feb; 7(2):82-8. PubMed ID: 4688500 [No Abstract] [Full Text] [Related]
5. [Surface tension within the lung and hyaline membrane disease]. Benzer H; Lempert J; Regele H Wien Klin Wochenschr; 1969 Feb; 81(9):145-9. PubMed ID: 5784059 [No Abstract] [Full Text] [Related]
6. [Pulmonary surfactan. Current physiological and physiopathological concepts]. Pariente R Presse Med (1893); 1969 Nov; 77(50):1871-2. PubMed ID: 5197179 [No Abstract] [Full Text] [Related]
7. Neonatal hyaline membrane disease: light and electron microscopical studies. Lauweryns JM; Bourgeois N Aspen Emphysema Conf; 1968; 11():3-32. PubMed ID: 5711556 [No Abstract] [Full Text] [Related]
8. Physiological basis and clinical implications of continuous negative chestwall pressure in hyaline membrane disease. Vidyasagar D Int Anesthesiol Clin; 1974; 12(4):153-71. PubMed ID: 4613660 [No Abstract] [Full Text] [Related]
9. [A study of the perfusion of the ventilated alveolar areas in hyaline membrane disease]. Hernandorena X; Dehan M; Boulley AM; Ropert JC; Saby MA; Gabilan JC Arch Fr Pediatr; 1982 Oct; 39(8):595-600. PubMed ID: 7159157 [TBL] [Abstract][Full Text] [Related]
10. A model of the effect of surfactant treatment on gas exchange in hyaline membrane disease. Cotton RB Semin Perinatol; 1994 Feb; 18(1):19-22. PubMed ID: 8209282 [No Abstract] [Full Text] [Related]
11. [Pathogenetic considerations on hyaline membrane disease of the lung in adults (study based on 23 autopsy findings)]. Giarelli L; Silvestri F; Ritella G; Mocavero G Pathologica; 1978; 70(1003-1004):251-65. PubMed ID: 581092 [No Abstract] [Full Text] [Related]
13. [Surface-active factor of the lungs (surfactant) in certain diseases of the respiratory organs]. Puchkov GF; Iazvinskiĭ II Sov Med; 1975 Aug; (8):62. PubMed ID: 1105810 [No Abstract] [Full Text] [Related]
14. Pulmonary surfactant and respiratory distress. Giammona ST GP; 1969 Jun; 39(6):86-90. PubMed ID: 5771122 [No Abstract] [Full Text] [Related]
15. [Anti-atelectasis factor (surfactant) and hyaline membrane disease in premature infants]. Saule H Med Klin; 1975 Mar; 70(10):409-15. PubMed ID: 1091827 [No Abstract] [Full Text] [Related]
16. Expansion pressures and rupture pressures in the newborn lung. Rosen M; Laurence KM Lancet; 1965 Oct; 2(7415):721-2. PubMed ID: 4157778 [No Abstract] [Full Text] [Related]
17. [Importance of the "surfactant system" in the pathogenesis of hyaline membrane in the newborn]. Cosmi EV; Condorelli S; Scarpelli EM Acta Anaesthesiol; 1970; 31():Suppl:69-94. PubMed ID: 5538013 [No Abstract] [Full Text] [Related]